Cedars-Sinai Medical Center

medical staff pulse newsletter

Text size: A A A
A BI-WEEKLY PUBLICATION FROM THE CEDARS-SINAI CHIEF OF STAFF Sept. 26, 2014 | Archived Issues

P and T Approvals, Details About Tramadol Change

Pharmacy Focus

See highlights of the Aug. 5 meeting of the Pharmacy and Therapeutics Committee. Also, more details are available about tramadol's new status as a controlled substance.

» Read more


Meetings and Events


Grand Rounds

Click here to view upcoming grand rounds.


Upcoming CME Conferences

Click below to view a complete list of all scheduled Continuing Medical Education conferences.

CME Newsletter - September (PDF)


Milestones

Do you know of a significant event in the life of a medical staff member? Please let us know, and we'll post these milestones in Medical Staff Pulse. Also, feel free to submit comments on milestones, and we'll post the comments in the next issue. Click here to email us your milestones and comments.

» Read more

Share Your News

Won any awards or had an article accepted for publication? Share your news about professional achievements and other items of interest.

Click here to share your news

How to Respond to the Possibility of Enterovirus

The federal Centers for Disease Control and Prevention (CDC) has released a Morbidity and Mortality Weekly Report on a severe respiratory illness associated with Enterovirus D68 (EV-D68).

Healthcare providers should consider EV-D68 as a possible cause of acute, unexplained, severe respiratory illness, particularly in young children and those with pre-existing asthma.

All patients with symptoms of viral respiratory illness should be placed in both contact and droplet isolation until etiology of the infection is determined.

Pediatric Infectious Disease consultation should be considered in seriously ill children to aid with appropriate specimen collection and testing, and to work with the appropriate public health authorities.

Laboratory testing of respiratory specimens for enteroviruses can be considered when the cause of respiratory infection in severely ill patients is unclear.

The Cedars-Sinai Microbiology Laboratory does not offer a specific test for EV-D68. State health departments or the CDC will be approached for enterovirus typing.

Viral cultures from throat and stool should be considered in patients suspected of having severe enteroviral disease. Enteroviruses are best isolated from these sites.

A multiplex respiratory PCR panel is offered in the Cedars-Sinai Microbiology Lab. It should be ordered only for:

  • Critically ill patients in the Intensive Care Unit (ICU)
  • Children who are immunocompromised or in the ICU
  • Post-transplant or immediately pretransplant patients

The panel detects enteroviruses but does not specifically subtype EV-D68.

Collect a high nasal swab (inserted high in the nasal passage, not nares) or nasopharyngeal swab placed in universal transport media (UTM) for transport to the Microbiology Lab (tube station 271).

If you have questions:

  • About patient evaluation, contact Pediatric Infectious Disease at ext. 3-4471
  • About isolation precautions, contact Hospital Epidemiology at ext. 3-5574
  • About microbiologic testing, contact the Microbiology Lab at ext. 3-4778

This CDC page has more information about EV-D68.